Balthaser Kevin sold ACRS
March 1, 2024 · Form 4 insider transaction
Balthaser Kevin sold 677 shares of Aclaris Therapeutics, Inc. at $1.24 per share, a transaction worth $839.48. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
677
Price
$1.24
Total value
$839.48
InsiderBalthaser Kevin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 1, 2024
Filing dateMarch 5, 2024
Shares owned after22,910
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.